Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD
SHANGHAI, Jan. 6, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate Chloride and...
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes
- The P hase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30 in participants with diabetes. Enrollment is expected to begin in the...
GAC Receives Industry's First Vehicle Data Security Management System Certificate
TIANJIN, China and GUANGZHOU, China, Dec. 31, 2025 /PRNewswire/ -- On December 24th, GAC received renewed authoritative recognition in vehicle data security by obtaining the industry's first Vehicle Data Security Management System Certification...
WF International Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
CHENGDU, China, Dec. 31, 2025 /PRNewswire/ -- WF International Limited (the "Company" or "WF International") (NASDAQ: WXM), an integrated electromechanical solutions company specializing in the supply, installation, fitting-out, and maintenance of...
China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite instability-high or mismatch repair deficient (MSI-H/dMMR)...
FP Markets Celebrates 20 Years of Transforming Trading and Looks Ahead to a New Era of Growth
SYDNEY, Dec. 24, 2025 /PRNewswire/ -- Global multi-asset broker FP Markets proudly marked its twentieth anniversary this year, celebrating two decades of 'Transforming Trading' through innovation, performance-driven technology, and a commitment to...
Cloopen Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
BEIJING, Dec. 24, 2025 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that its Board of Directors (the "Board") has received a preliminary non-binding proposal letter (the "Proposal"), dated...
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Gastric Cancer.
SEONGNAM, South Korea, Dec. 24, 2025 /PRNewswire/ -- SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gastroesophageal junction cancer) to SNB-101...
RunCloud CEO Arif Tukiman Honoured with Top Entrepreneur at UTM Alumni Homecoming
Forbes 30 Under 30 recipient and global tech leader recognized for his transformative impact on Malaysia's digital innovation ecosystem. KUALA LUMPUR, Malaysia, Dec. 19, 2025 /PRNewswire/ -- Muhammad Arif bin Tukiman, the visionary co-founder and...
How to Find the Best Tutors Quickly and Safely with the Award-Winning Tutor Circle
HONG KONG, Dec. 16, 2025 /PRNewswire/ -- With parents placing greater emphasis on tutor credibility and transparency, Tutor Circle , a leading tutor matching platform based in Hong Kong, is strengthening its verification and quality-assurance...